Keyphrases
Hepatitis C Virus
100%
MELD Score
62%
Meta-analysis
50%
Shunt Placement
50%
Current Management
50%
Predictive Models
50%
Vibration-controlled Transient Elastography
50%
Liver Cirrhosis
50%
Infected Population
50%
Transjugular Intrahepatic Portosystemic Shunt
50%
Functional Constipation
50%
Chronic Hepatitis C
50%
Fibrosis-4 Score
50%
Alcoholic Hepatitis
50%
Vitamin D
50%
Liver Model
50%
Clinical Trial Data
50%
Fibrosis-4 (FIB-4)
50%
Systematic Meta-analysis
50%
Hepatitis Treatment
50%
Future Therapies
50%
Liver Fibrosis
50%
25(OH)D Level
33%
Hepatitis C
33%
AIDS/HIV
33%
Liver Biopsy
33%
Liver Disease
29%
Etiology
29%
Liver Transplantation
26%
Severe Alcoholic Hepatitis
25%
Severe Disease
25%
Pentoxifylline
25%
Negative Predictive Value
21%
Positive Predictive Value
21%
Liver Stiffness
21%
Uncertainty Measure
16%
Inclusion Criteria
16%
Odds Ratio
16%
Literature Search
16%
Advanced Fibrosis
16%
Scopus
16%
PubMed
16%
Pediatric Patients
16%
Corresponding Measures
16%
Low Quality Data
16%
Fibrosis
16%
Rome III Criteria
16%
Bristol
16%
Mental Component Summary Scores
16%
SF-36 Score
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vitamin D
100%
Liver Fibrosis
100%
Fibrosis
98%
Hepatitis C Virus
87%
Chronic Hepatitis C
66%
Nonalcoholic Fatty Liver
50%
Liver Cirrhosis
50%
Alcohol Liver Disease
50%
Clinical Trial
50%
Disease
35%
Liver Disease
32%
HIV
25%
Hepatitis C
18%
Ethanol
14%
Infection
14%
Pentoxifylline
14%
25 Hydroxyvitamin D
7%
Combination Therapy
7%
Drug Discovery
7%
Alcohol Liver Cirrhosis
7%
End Stage Liver Disease
7%
Receptor
7%
Hepatic Encephalopathy
7%
Fatty Liver
7%
Transcription Factors
7%
Tumor Necrosis Factor Inhibitor
7%
Placebo
7%
Non Erosive Reflux Disease
5%
Medicine and Dentistry
Alcohol Liver Disease
50%
Liver Cirrhosis
50%
Hepatitis C Virus
50%
Fibrosis
50%
Transient Elastography
50%
Disease
35%
Chronic Hepatitis C
16%
Liver Transplantation
14%
Infection
14%
Pentoxifylline
14%
Hepatic Encephalopathy
7%
Cell Death
7%
Supportive Care
7%
Stem Cell Therapy
7%
Gut
7%
Receptor
7%
Abstinence
7%
Alcohol Liver Cirrhosis
7%
Discriminant Analysis
7%
Transcription Factors
7%
Induced Pluripotent Stem Cell
7%
Innate Immunity
7%
Liver Disease
7%
Fatty Liver
7%
Model for End-Stage Liver Disease
7%
TNF Inhibitor
7%
Placebo
7%
Combination Therapy
7%
Alcohol Abstinence
7%
Chronic Laryngitis
5%
Non Erosive Reflux Disease
5%
Hepatitis C
5%
